Attentional Capacity and Working Memory in Coronary Artery Disease Patients: Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With CPAP (CAPCORSAS)

Centre Hospitalier Universitaire de Saint Etienne

Status: Terminated

Conditions: Acute Coronary Syndrome; Obstructive Sleep Apnea

Treatments: Device: CPAP treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT02533050

1308171

2013-A01635-40 (Other Identifier)

Details and patient eligibility

About

The presence of Obstructive Sleep Apnea Syndrome (OSAS) has a high frequency in patients victims of a coronary artery disease (CAD) (myocardial infarction, revascularization). Unlike patients seen in a sleep Laboratory with an impact on daytime functioning, CAD apneic patients do not complain in their daytime functioning. The objective of this study is to explore whether the objective cognitive assessment measures may be a good marker of the efficacy of CPAP treatment given to non-sleepy apneic CAD patients.

Coronary patients with an AHI between 15 and 40 / h will be treated (or not) after randomization with CPAP treatment. The expected results are: CPAP apneic coronary patients should have a positive impact on cognitive performance, particularly on attention span and working memory measured by improvement in the Paced Auditory Serial Addition Test score (PASAT score).

Enrollment: 9 patients

Sex: All

Ages: 30 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient admitted to the Clinical Physiology Department of Exercise of the Saint Etienne University Hospital (myocardial infarction, coronary stenting or coronary artery bypass) and referred for care in cardiac rehabilitation
• A native French speaker
• No daytime sleepiness (ESS <or = 10)
• Signature of informed consent by the patient

Exclusion criteria

• Patients with a previous diagnosis of sleep apnea syndrome
• Patients with severe heart failure (stage III and IV of the NYHA)
• Patients with a neurodegenerative disease or other known cognitive disorders
• Presence of progressive disease other than coronary artery disease (cancer for example)
• Patients participating in other research that can change their cognitive function or drowsiness

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

9 participants in 3 patient groups

Patients treated

Experimental group

Description:

Patients with CAD and SAS. This patients should have an apnea-hypopnea index (AHI) between 15 and 40, and an Epworth sleepiness score (ESS) \<10. After randomization, they will be treated with CPAP treatment.

Treatment:

Device: CPAP treatment

Patients non-treated

No Intervention group

Description:

Patients with CAD and SAS. This patients should have an apnea-hypopnea index (AHI) between 15 and 40, and an ESS \<10. After randomization, they will be not treated.

Control group

No Intervention group

Description:

Patients with CAD but without SAS (AHI\<15).